Biological Products, (No Diagnostic Substances) · DE · CIK 1619856
Develops transformative allogeneic CAR-T cell therapies for devastating diseases using novel genome-editing technology
Comparable business profile · signals at a glance
In the 90 days to Feb 25, 2026: 4 sold $47K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2026 | Kelly Timothy PChief Technology Officer | Sell | 6,228 | $1.93 | $12K |
| Feb 24, 2026 | Mcclung Barbara GChief Legal Officer | Sell | 6,938 | $1.96 | $14K |
| Feb 24, 2026 | Khan Ruhi AhmadChief Business Officer | Sell | 6,938 | $1.96 | $14K |
| Feb 24, 2026 | Kelly Timothy PChief Technology Officer | Sell | 3,147 | $1.96 | $6K |
| Feb 24, 2026 | Albertson Tina M.Chief Medical Officer | Sell | 1,066 | $1.96 | $2K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.